- Report
- October 2024
- 192 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- December 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- December 2024
- 146 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- October 2024
- 200 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- November 2024
- 186 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 185 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- August 2024
- 142 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- November 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- November 2022
- 295 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- February 2024
- 255 Pages
Global
From €4235EUR$4,455USD£3,558GBP
€4706EUR$4,950USD£3,953GBP
- Report
- June 2023
- 186 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- March 2021
- 216 Pages
Global
From €1307EUR$1,375USD£1,098GBP
€2614EUR$2,750USD£2,196GBP
- Report
- November 2022
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- October 2023
- 89 Pages
Canada
From €3327EUR$3,500USD£2,795GBP
- Report
- June 2023
- 112 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2022
- 115 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- October 2022
- 163 Pages
Global
From €3422EUR$3,600USD£2,875GBP
- Report
- October 2024
- 104 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- July 2023
- 95 Pages
Global
From €3500EUR$3,944USD£3,043GBP

Genomic biomarkers are a type of biomarker that are used to identify and measure genetic material in a biological sample. They are used to detect genetic variations that can be used to diagnose and monitor diseases, predict drug response, and identify individuals at risk for certain conditions. Genomic biomarkers are used in a variety of applications, including personalized medicine, drug development, and diagnostics.
Genomic biomarkers are typically identified through the analysis of DNA, RNA, and proteins. They can be used to detect genetic variations that are associated with diseases, such as cancer, and to identify individuals at risk for certain conditions. Genomic biomarkers can also be used to predict drug response and to monitor the progression of diseases.
The genomic biomarker market is expected to grow significantly in the coming years, driven by advances in technology and the increasing demand for personalized medicine. Companies in the market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and Roche. Show Less Read more